Clementia Pharmaceuticals Inc (NASDAQ: CMTA) has appointed Steve Forte as chief financial officer, effective from 3 August 2018.

Forte will take over from the company's current CFO, Michael Singer, who will transition from his role as of 9 August 2018.

Announcing the appointment, Clementia CEO Clarissa Desjardins said that Forte has "extensive financial experience and proven leadership serving large, multinational commercial-stage companies".

Most recently, Forte served as CFO of Canadian financial technology firm Thinking Capital Financial Corporation, where he helped lead the firm through rapid growth and ultimately to a successful sale of the company to Purpose Investments.

Earlier, he spent nearly a decade working at Aptalis Pharma Inc, where he oversaw the corporate controllership function. Forte was also responsible for SEC reporting and led the preparation of an SEC S-1 registration statement for a US IPO on NASDAQ prior to the successful sale of the company to Forest Labs for USD2.9bn. Additionally, Forte led the financial due diligence efforts leading to several acquisitions, including that of a key competitor worth USD650m.